CEO Kevin J. McNamara sells $1.08M of Chemed Corp stock
After the sale, the filing lists 82,220 shares held. Information only, not investment advice.
Kevin J. McNamara, a chief executive officer of Chemed Corp (CHE), sold 2,000 shares on Nov 3 at an average price of $537.90, a total of about $1.1 million, according to a Form 4 filed with the SEC on Nov 5.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. After the trade, the filing lists 82,220 shares held.
The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Chemed Corp (CHE) |
|---|---|
| Insider | Kevin J. McNamara |
| Role | CEO |
| Transaction | Open-market sale (code S) |
| Shares | 2,000 |
| Average price | $537.90 |
| Value | $1,075,800 |
| Trade date | Nov 3, 2026 |
| Filed with the SEC | Nov 5, 2026, 3:34 PM ET |
| Shares held after | 82,220 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
Open the full breakdown of this CHE trade
See the biggest insider trades of each day · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Chemed president and CEO Kevin McNamara sells $1.03M in stock
- Insider Trading News
Cme Group Inc. officer Julie Winkler sells $3.08M in stock
- Insider Trading News
Patricia Carr, an SVP, chief accounting officer at Jazz Pharmaceuticals plc, sells $326,910 of stock
- Insider Trading News
President Brian S. Olschan sells $1.07M of Acme United Corp stock
- Insider Trading News
Healthstream Inc executive vice president Kevin P O'Hara sells $124,437 in shares